Trade Pfizer ^PFE

Exclusive-Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles

Pfizer Wins €1.9 Billion Covid Vaccine Case With Poland, Romania

Belgian court orders Poland, Romania to buy $2.2 billion of Pfizer COVID vaccines

Pfizer Pulls Back From South San Francisco

Doxorubicin Market Outlook 2026-2030 & 2035: Predicted to Surge to $2 Billion by 2030, Bolstered by Expanding Access to Cancer Care

Rapid Growth in Paclitaxel Injection Market: From $7.68 Billion in 2026 to $12.72 Billion by 2030

Pfizer (PFE) Valuation Check As Phase 3 Lyme Vaccine And Prostate Cancer Results Draw Focus

Meyer Handelman Co. Sells 50,802 Shares of Pfizer Inc. $PFE

Pfizer Inc. $PFE Shares Bought by Capital Advisors Inc. OK

Vaughan Nelson Investment Management L.P. Reduces Holdings in Pfizer Inc. $PFE - Stock Observer

Shrier Wealth Management LLC Takes Position in Pfizer Inc. $PFE - Daily Political

Loss of luminal lineage drives resistance to next-generation ERα antagonists in pretreated ER+ HER2− locally-advanced or metastatic breast cancer

Pfizer (NYSE:PFE) Stock Price Up 1.1% - Here's What Happened - Markets Daily

Pharmaceutical Stocks To Watch Today - March 31st

Pfizer (NYSE:PFE) Trading Up 1.1% - What's Next? - Stock Observer

Here's Why You Don't Bet Against This Dividend King

Mizuho Lifts PT on BridgeBio Pharma (BBIO) to $106 From $91 - Here's Why

Kidney Cancer Drugs Market to Grow by $2 Billion During 2026-2030: Pfizer, Novartis, Exelixis, Roche, Bristol Myers Squibb Company, and Bayer Lead the Industry

Ovarian Cancer Drugs Market Outlook Report 2026-2030 Featuring Strategic Analysis of AstraZeneca, Roche, Bristol-Myers Squibb Company, Clovis Oncology, Pfizer and Other Key Players

Pfizer (NYSE:PFE) Hits New 52-Week High - Should You Buy? - Daily Political

Is It Time To Reconsider Pfizer (PFE) After Diverging Valuation Narratives?

Pfizer (NYSE:PFE) Shares Up 2.6% - Time to Buy?

Announced in June, positive topline results from registratio

Pfizer's (PFE) Shares Up Since Jim Cramer Said "Pass"

Eli Lilly's (LLY) Shares Up Since Jim Cramer Said He Was a Long Term Believer

$1.59 Billion PD-1 Resistant Head and Neck Cancer Market Analysis Report 2026: Size, Growth, and Segmentation Insights to 2030

Pancreatic Adenocarcinoma Treatment Market to Grow at 13% CAGR During 2026-2030, Led by Pfizer, Roche, Merck & Co., Sanofi, Bristol-Myers Squibb, AstraZeneca, Novartis, and GlaxoSmithKline

Cancer Cachexia Market Outlook Report 2026-2030: Personalized Treatments and Digital Tools Elevate Cancer Cachexia Care; Total Revenue to Grow by $600 Million

Non-Small Cell Lung Cancer (NSCLC) Global Market Trends and Regional Growth Insights 2026-2030: Rapid Adoption of Targeted Therapies and Immunotherapy Fuels Market Expansion, Reaching $70.8 Billion by 2030

Esophageal Cancer Market to Grow from $1.65 Billion in 2026 to $2.37 Billion by 2030: Pfizer, Roche, Merck & Co. Dominate

Pfizer (PFE) - Among the 15 Large Cap Stocks with Highest Dividends

Prediction: Buying Pfizer Stock Today Could Set You Up for Life

Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial

Jim Cramer's Hottest GLP-1 and Weight Loss Stock Picks: Top 5 Stocks

Pfizer (NYSE:PFE) Stock Price Down 2% - Here's What Happened

Pfizer Inc. (NYSE:PFE) Receives Consensus Recommendation of "Hold" from Analysts

Characterization, immune cell phenotyping and differential gene expression analysis of brain metastases and primary breast cancer samples

Pfizer Oncology Wins Raise Questions On Valuation Gap And Future Revenues

Novo Nordisk Voucher Win Meets Rising Scrutiny Of FDA Review Program

Top Pharmaceutical Stocks To Watch Today - March 25th - Markets Daily

PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026

Exchange Traded Concepts LLC Sells 60,810 Shares of Pfizer Inc. $PFE - Stock Observer

Pfizer (NYSE:PFE) Trading Down 2% - Here's Why

Preliminary Results for the Year Ended 31 December 2025

Jim Cramer on Pfizer: "I Just Need to Know Their Product Flow Better"

Jim Cramer Broke Down 5 Stocks Including Pharma Plays for Rising Oil

Should Pfizer's (PFE) New Lyme Vaccine and Oncology Wins Reshape Its Post‑COVID Pipeline Story?

Is Pfizer's Late‑Stage Lyme Vaccine Progress Reshaping the Investment Case for PFE?

Pfizer Inc. $PFE Shares Acquired by Fort Washington Investment Advisors Inc. OH

Guggenheim Sees Favorable Risk-Reward for Pfizer (PFE) Ahead of Phase 3 Data

Income Investors Face a Hard Truth About Pfizer's Payout Safety

Pfizer Lyme Vaccine Readout Adds New Angle To Valuation Debate

Pfizer Inc. $PFE Stock Holdings Increased by Czech National Bank

Branded Pharmaceuticals Stocks Q4 Recap: Benchmarking Collegium Pharmaceutical (NASDAQ:COLL)

Vaccine for Lyme disease one step closer to coming to market - CBS New York

Pfizer (NYSE:PFE) Shares Up 1.2% After Analyst Upgrade

Pfizer Inc. (PFE) Announces Positive Topline Results From Phase 3 TALAPRO-3 Study of TALZENNA®

This 6.5%‑Yielding Dividend Payer is Sitting on a Breakthrough Investors Haven't Priced In

The Iran War Could Make Your Next MRI More Expensive

Pensionfund Sabic Makes New Investment in Pfizer Inc. $PFE - Markets Daily

Top Pharmaceutical Stocks To Watch Today - March 25th - Daily Political

Valneva (NASDAQ:VALN) Sees Unusually-High Trading Volume - Time to Buy? - Stock Observer

A Look At Pfizer (PFE) Valuation As Shares Trade Near Recent Levels

Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial

Doctors say Lyme disease vaccine trial results 'encouraging' with 70% efficacy shown - Yahoo News Canada

Doctors say Lyme disease vaccine trial results 'encouraging' with 70% efficacy shown - AOL

IP Group - Call Option on Pfizer's Anti-Obesity Program | Investing.com UK

Pfizer Inc. $PFE Shares Bought by SG Americas Securities LLC - Markets Daily

Pfizer Could Hit $36 by Year-End as Analysts See 2-to-1 Payoff on Key Prostate Cancer Trial

Pfizer Reports 73% Lyme Vaccine Efficacy as Trial Results Complicate Outlook

Company Website: https://www.pfizer.com NEW YORK -- (Busin

Pfizer (NYSE:PFE) Price Target Raised to $36.00

Pfizer working for approval on new Lyme disease vaccine as expert says tick activity rising in New England

Pfizer Inc. $PFE Shares Acquired by SG Americas Securities LLC

Park Place Capital Corp Trims Position in Pfizer Inc. $PFE

Organon: A High Cash Yield Hidden Behind Patent Fatigue | Investing.com Canada

Pfizer and Valneva's Lyme Disease Vaccine Demonstrates Over 70% Efficacy in Key Trial, ETPharma

Enhanced dynamic risk stratification of smoldering multiple myeloma

Pfizer working to get approval on new Lyme disease vaccine. Expert says tick activity rising in New England. - CBS Boston

Pfizer says Lyme disease vaccine is holding promise - CBS Boston

Q4 Earnings Outperformers: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals Stocks

Pfizer Lyme Vaccine Data Adds New Angle To Vaccine Portfolio Story

Health Care Up, but Not by Much, Amid Cyclical Rotation - Health Care Roundup | Morningstar

Dow Jones Top Company Headlines at 3 PM ET: Danone to Buy Protein-Shake Maker Huel for $1.2 Billion | Toyota ... | Morningstar

Is Pfizer (PFE) Offering Value After Its Post Covid Portfolio Shift And Mixed Returns?

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Meta Platforms: Navigating Legal Headwinds and AI Opportunities for Investors

US Stocks Poised for Potential Rebound Amidst Easing Geopolitical Tensions and Shifting Investor Positioning

Investing in US Stocks from South Africa: Step-by-Step Guide for ZA Investors

How to Invest in Stocks for Beginners (Europe): Opportunities, Risks and Smart Strategies in 2026

Forex Market Today: BRICS+ Currency Dynamics, USD/AED Stability, Key Currency Trading Opportunities

European Stocks Overview: European Shares Slide as Middle East Conflict Fuels Inflation Fears

Lucid Group (LCID) stock dropped 98%: Should you buy the deep? Is LCID stock a good investment?

Michael Burry Bets Against Nvidia & Palantir Amid AI Boom: A Bubble?

Ukraine Forges New Alliances in the Middle East, Leveraging Defense Expertise

US Reinforces Middle East Presence Amid Escalating Tensions with Iran

Fed Policy Pivot: Inflation Risks Hint at Potential Rate Hikes, Shifting Market Expectations

TotalEnergies Dominates Middle East Oil Market in March, Securing Record Profits

Navigating Economic Crosscurrents: Market Outlook Amidst Geopolitical Turmoil

Ukraine Hints at Reduced Strikes on Russian Energy Amid Partner Pressure, Secures Middle East Support

Hormuz Strait Tensions Escalate: US Threatens 'Total Destruction' Amidst Regional Proxy Engagements

Nasdaq Accelerates New Listings into Key Indices Amidst Mega IPO Preparations